CD79A and COVID-19: In a study conducted in Wuhan Hospital (Wuhan, China), serum IgM and IgA antibodies against SARS-CoV-2 were detectable 3–6 days and serum IgG antibody 10–18 days post clinical symptoms onset in COVID-19 patients by ELISA based on the viral nucleocapsid protein [20].